Advertisement
Screener

JUNIPER PHARMACEUTICALS INC Dilutive Securities, Effect on Basic Earnings Per Share

JUNIPER PHARMACEUTICALS INC Dilutive Securities, Effect on Basic Earnings Per Share

JUNIPER PHARMACEUTICALS INC reported Dilutive Securities, Effect on Basic Earnings Per Share of $0 for the 3-month period ending 2016-06-30, per its 10-Q filed 2016-08-04.

Discontinued › Income Statement › Earnings Per Share

us-gaap:DilutiveSecurities · last filed 2017-03-07

  • JUNIPER PHARMACEUTICALS INC dilutive securities, effect on basic earnings per share for the quarter ending 2016-06-30 was $0.00.
  • JUNIPER PHARMACEUTICALS INC dilutive securities, effect on basic earnings per share for the quarter ending 2015-06-30 was $0.00.
  • JUNIPER PHARMACEUTICALS INC dilutive securities, effect on basic earnings per share for the quarter ending 2014-12-31 was $1.00K.
  • JUNIPER PHARMACEUTICALS INC dilutive securities, effect on basic earnings per share for the quarter ending 2014-09-30 was -$1.00K, a 100.23% decline year-over-year.
  • JUNIPER PHARMACEUTICALS INC dilutive securities, effect on basic earnings per share for fiscal 2014 was -$379.00K.
  • JUNIPER PHARMACEUTICALS INC dilutive securities, effect on basic earnings per share for fiscal 2013 was -$794.00K, a 111.35% decline from fiscal 2012.
  • JUNIPER PHARMACEUTICALS INC dilutive securities, effect on basic earnings per share for fiscal 2012 was $7.00M.
  • JUNIPER PHARMACEUTICALS INC dilutive securities, effect on basic earnings per share for fiscal 2011 was -$556.66K.
Period endDilutive Securities, Effect on Basic Earnings Per Share 3 monthDilutive Securities, Effect on Basic Earnings Per Share 3 month as first filedDilutive Securities, Effect on Basic Earnings Per Share 6 monthDilutive Securities, Effect on Basic Earnings Per Share 6 month as first filedDilutive Securities, Effect on Basic Earnings Per Share 9 monthDilutive Securities, Effect on Basic Earnings Per Share 9 month as first filedDilutive Securities, Effect on Basic Earnings Per Share 12 monthDilutive Securities, Effect on Basic Earnings Per Share 12 month as first filed
2016-06-30$0.00
10-Q · filed 2016-08-04
$0.00
10-Q · filed 2016-08-04
2015-06-30$0.00
10-Q · filed 2016-08-04
$0.00
10-Q · filed 2016-08-04
2014-12-31$1.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-07
$0.00
derived: sum of 2 quarters · filed 2017-03-07
-$70.00K
derived: sum of 3 quarters · filed 2017-03-07
-$379.00K
10-K · filed 2017-03-07
$380.00K
10-K · filed 2015-03-18
2014-09-30-$1.00K
10-Q · filed 2015-11-12
$1.00K
10-Q · filed 2014-10-31
-$71.00K
derived: sum of 2 quarters · filed 2015-11-12
-$380.00K
10-Q · filed 2015-11-12
$380.00K
10-Q · filed 2014-10-31
-$1.65M
derived: sum of 4 quarters · filed 2016-11-14
2014-06-30-$70.00K
10-Q · filed 2015-08-04
$70.00K
10-Q · filed 2014-08-01
-$379.00K
10-Q · filed 2015-08-04
$379.00K
10-Q · filed 2014-08-01
-$1.65M
derived: sum of 3 quarters · filed 2016-11-14
-$1.22M
derived: sum of 4 quarters · filed 2016-11-14
2014-03-31-$309.00K
10-Q · filed 2015-05-06
-$1.58M
derived: sum of 2 quarters · filed 2016-11-14
-$1.15M
derived: sum of 3 quarters · filed 2016-11-14
-$898.00K
derived: sum of 4 quarters · filed 2016-11-14
2013-12-31-$1.27M
derived: 10-K/A 12 month − 10-Q 9 month · filed 2016-11-14
-$844.00K
derived: sum of 2 quarters · filed 2016-11-14
-$589.00K
derived: sum of 3 quarters · filed 2016-11-14
-$794.00K
10-K/A · filed 2016-11-14
-$794.28K
10-K · filed 2014-03-05
2013-09-30$428.00K
10-Q · filed 2014-10-31
-$427.66K
10-Q/A · filed 2014-03-03
$683.00K
derived: sum of 2 quarters · filed 2014-10-31
$478.00K
10-Q · filed 2014-10-31
-$477.68K
10-Q/A · filed 2014-03-03
$12.87M
derived: sum of 4 quarters · filed 2015-03-18
2013-06-30$255.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-01
$50.00K
10-Q · filed 2014-08-01
-$50.03K
10-Q · filed 2013-08-07
$12.44M
derived: sum of 3 quarters · filed 2015-03-18
$12.44M
derived: sum of 4 quarters · filed 2015-03-18
2013-03-31-$205.00K
10-Q · filed 2014-05-02
-$204.77K
10-Q · filed 2013-05-09
$12.19M
derived: sum of 2 quarters · filed 2015-03-18
$12.19M
derived: sum of 3 quarters · filed 2015-03-18
$11.98M
derived: sum of 4 quarters · filed 2015-03-18
2012-12-31$12.39M
derived: 10-K 12 month − 10-Q/A 9 month · filed 2015-03-18
$12.39M
derived: sum of 2 quarters · filed 2015-03-18
$12.19M
derived: sum of 3 quarters · filed 2015-03-18
$7.00M
10-K · filed 2015-03-18
$7.00M
10-K · filed 2013-03-14
2012-09-30$0.00
10-Q · filed 2012-11-08
-$205.70K
derived: sum of 2 quarters · filed 2013-08-07
-$5.40M
10-Q/A · filed 2014-03-03
-$4.23M
derived: sum of 4 quarters · filed 2014-03-05
2012-06-30-$205.70K
10-Q · filed 2013-08-07
-$6.47M
10-Q · filed 2013-08-07
-$4.23M
derived: sum of 3 quarters · filed 2014-03-05
-$9.28M
derived: sum of 4 quarters · filed 2014-03-05
2012-03-31-$6.26M
10-Q · filed 2013-05-09
-$4.03M
derived: sum of 2 quarters · filed 2014-03-05
-$9.08M
derived: sum of 3 quarters · filed 2014-03-05
-$11.87M
derived: sum of 4 quarters · filed 2014-03-05
2011-12-31$2.23M
derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-05
-$2.82M
derived: sum of 2 quarters · filed 2014-03-05
-$5.61M
derived: sum of 3 quarters · filed 2014-03-05
-$556.66K
10-K · filed 2014-03-05
$556.66K
10-K · filed 2013-03-14
2011-09-30-$5.05M
10-Q · filed 2012-11-08
-$7.85M
derived: sum of 2 quarters · filed 2012-11-08
-$2.79M
10-Q · filed 2012-11-08
2011-06-30-$2.80M
10-Q · filed 2012-08-08
$0.00
10-Q · filed 2012-08-08
2010-12-31$0.00
10-K · filed 2013-03-14